Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lafayette, IN
NPI
1275912602
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3920 St Francis Way Ste 220
Lafayette, IN, 47905
Phone (765) 428-5950
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
1,091 services
Medicare patients, 2024
356
Average age 72
Drug cost, 2024
$2.2M
4,311 prescriptions
Company payments, 2024
$88.89
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel L Worsham was code 99214 (office e&m - established), 324 times for 237 patients. In total Samuel L Worsham billed 1,091 services in 12 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 324 | 237 | $78.12 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 183 | 155 | $11.47 | $2,098 |
| 99232 Hospital E&M - Subsequent | Facility | 148 | 54 | $57.27 | $8,477 |
| 99214 Office E&M - Established | Facility | 116 | 114 | $71.85 | $8,335 |
| 95251 Test - Miscellaneous | Office | 90 | 62 | $23.81 | $2,143 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 54 | 54 | $12.23 | $660 |
| 99222 Hospital E&M - Initial | Facility | 45 | 45 | $91.62 | $4,123 |
| 95251 Test - Miscellaneous | Facility | 42 | 42 | $25.75 | $1,082 |
| 99204 Office E&M - New | Office | 38 | 38 | $97.72 | $3,713 |
| 99215 Office E&M - Established | Office | 18 | 16 | $109.83 | $1,977 |
| 99205 Office E&M - New | Office | 11 | 11 | $116.37 | $1,280 |
By year: 2022 $45K for 524 services; 2023 $61K for 768 services; 2024 $61K for 1,091 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel L Worsham prescribed most often to Medicare patients was Levothyroxine Sodium, with 476 prescriptions and refills. In total Samuel L Worsham wrote 4,311 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 476 | 1,167 | 110 | $4,181 |
| Ozempic Semaglutide | 347 | 598 | 88 | $578K |
| Metformin Hcl Er Metformin Hcl | 274 | 715 | 82 | $3,275 |
| Mounjaro Tirzepatide | 268 | 305 | 55 | $321K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 202 | 430 | 74 | $40K |
| Jardiance Empagliflozin | 167 | 388 | 52 | $224K |
| Trulicity Dulaglutide | 117 | 167 | 32 | $161K |
| Lisinopril Generic | 113 | 333 | 37 | $604 |
| Amlodipine Besylate Generic | 105 | 294 | 39 | $516 |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 157 | 29 | $37K |
| Alendronate Sodium Generic | 82 | 194 | 21 | $308 |
| Glimepiride Generic | 73 | 192 | 24 | $489 |
| Methimazole Generic | 73 | 205 | 24 | $599 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 70 | 112 | 25 | $28K |
| Atorvastatin Calcium Generic | 70 | 204 | 28 | $338 |
Brand drugs: 2,214 claims; generic drugs: 1,790 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Samuel L Worsham $88.89 ($88.89 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $84.03.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.